首页> 外文期刊>Inorganica Chimica Acta >Reactivity of [PdCl(mu-med)](2) with monodentate or bidentate ligands. Structure of the dinuclear complexes [Pd(mu-med)(PPh3)](2)(BF4)(2) and [Pd(mu-med)(bpy)](2)(BF4)(2). [Hmed = N-(2-mercaptoethyl)-3,5-dimethylpyrazole]
【24h】

Reactivity of [PdCl(mu-med)](2) with monodentate or bidentate ligands. Structure of the dinuclear complexes [Pd(mu-med)(PPh3)](2)(BF4)(2) and [Pd(mu-med)(bpy)](2)(BF4)(2). [Hmed = N-(2-mercaptoethyl)-3,5-dimethylpyrazole]

机译:[PdCl(mu-med)](2)与单齿或双齿配体的反应性。双核络合物[Pd(mu-med)(PPh3)](2)(BF4)(2)和[Pd(mu-med)(bpy)](2)(BF4)(2)的结构。 [Hmed = N-(2-巯基乙基)-3,5-二甲基吡唑]

获取原文
获取原文并翻译 | 示例
           

摘要

Treatment of the ligand N-(2-mercaptoethyl)-3,5-dimethylpyrazole with [Pd(CH3COO)(2)](3) and reaction of [PdCl(mu-med)](2) with pyridine (py) or triphenylphosphine (PPh3) in the presence of AgBF4 produced the following complexes: [Pd(CH3COO)(mu-med)](2), [Pd(mu-med)(py)](2)(BF4)(2) and [Pd(mu-med)(PPh3)](2)(BF4)(2). Similar reactions carried out with 2,2'-bipyridine (bpy) or 1,3-bis(diphenylphosphino)propane (dppp) produced [Pd(mu-med)(bpy)](x)(BF4)(x) (x = 1 or 2) and [Pd(mu-med)(dppp)](x)(BF4)(x) (x = 1 or 2). Treatment of [Pd(mu-med)(bpy)](x)(BF4)(x) with [PdCl2(CH3CN)(2)] produced [Pd3Cl2(mu-med)(2)(bpy)(2)](BF4)(2). Treatment of [Pd (mu-med)(dppp)](x)(BF4)(x) with [PdCl2(CH3CN)(2)] produced a mixture of [Pd(mu-Cl)(dppp)](2)(BF4)(2) and [Pd(mu-med)(2)(dppp)](2+). X-ray crystal structures of [Pd(mu-med)(PPh3)](2)(BF4)(2) . 2CH(3)CN and [Pd(mu-med)(bpy)](2)(BF4)(2) . 0.5CH(3)OH are presented. (C) 2003 Elsevier B.V. All rights reserved. [References: 50]
机译:用[Pd(CH3COO)(2)](3)处理配体N-(2-巯基乙基)-3,5-二甲基吡唑,并使[PdCl(mu-med)](2)与吡啶(py)或在AgBF4存在下,三苯基膦(PPh3)产生以下配合物:[Pd(CH3COO)(mu-med)](2),[Pd(mu-med)(py)](2)(BF4)(2)和[Pd(mu-med)(PPh3)](2)(BF4)(2)。用2,2'-联吡啶(bpy)或1,3-双(二苯基膦基)丙烷(dppp)进行的类似反应产生了[Pd(mu-med)(bpy)](x)(BF4)(x)(x = 1或2)和[Pd(mu-med)(dppp)](x)(BF4)(x)(x = 1或2)。用[PdCl2(CH3CN)(2)]处理[Pd(mu-med)(bpy)](x)(BF4)(x)产生的[Pd3Cl2(mu-med)(2)(bpy)(2)] (BF4)(2)。用[PdCl2(CH3CN)(2)]处理[Pd(mu-med)(dppp)](x)(BF4)(x)产生了[Pd(mu-Cl)(dppp)](2)的混合物(BF4)(2)和[Pd(mu-med)(2)(dppp)](2+)。 [Pd(mu-med)(PPh3)](2)(BF4)(2)的X射线晶体结构。 2CH(3)CN和[Pd(mu-med)(bpy)](2)(BF4)(2)。提出了0.5CH(3)OH。 (C)2003 Elsevier B.V.保留所有权利。 [参考:50]

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号